TP53 and breast carcinoma: Moreover, Lu et al. showed that, in the MCF7/ADM cell line of breast cancer, CIAPIN1 gene silencing by siRNA reduced the drug resistance against epirubicin, paclitaxel, and gemcitabine by regulating MDR1 and P53 expression [40].